The effects of hydroxychloroquine on endothelial dysfunction

Pregnancy Hypertens. 2016 Oct;6(4):259-262. doi: 10.1016/j.preghy.2016.09.001. Epub 2016 Sep 14.

Abstract

Hydroxychloroquine is an anti-malarial drug which, due to its anti-inflammatory and immunomodulatory effects, is widely used for the treatment of autoimmune diseases. In a model of systemic lupus erythematosus hydroxychloroquine has been shown to exert protective endothelial effects. In this study, we aimed to investigate whether hydroxychloroquine was endothelial protective in an in vitro model of TNF-α and preeclamptic serum induced dysfunction. We showed that hydroxychloroquine significantly reduced the production of TNF-α and preeclamptic serum induced endothelin-1 (ET-1). Hydroxychloroquine also significantly mitigated TNF-α induced impairment of angiogenesis. These findings support the further assessment of hydroxychloroquine as an adjuvant therapy in preeclampsia.

Keywords: Endothelial dysfunction; Endothelin-1; Hydroxychloroquine; Preeclampsia; Preeclamptic serum; TNF-α.

MeSH terms

  • Antimalarials / pharmacology*
  • Endothelin-1 / biosynthesis*
  • Female
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Hydroxychloroquine / pharmacology*
  • Neovascularization, Physiologic / drug effects
  • Pre-Eclampsia / blood
  • Pregnancy
  • Primary Cell Culture
  • Serum
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Antimalarials
  • Endothelin-1
  • Tumor Necrosis Factor-alpha
  • Hydroxychloroquine